{"entity":{"type":"insider","cik":"0001343811","url":"/insider/0001343811","json_url":"/insider/0001343811.json","name":"Provencio Norma Ann","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":29,"n_filings":20,"first":"2009-03-02","last":"2025-02-10","span_basis":"filed_date"},"name_variants":[{"name":"Provencio Norma Ann","source":"filing","n_filings":20,"first_seen":"2009-03-02","last_seen":"2025-02-10"}],"transactions":[{"id":5149198,"accession":"0000915840-25-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000915840-25-000028","line_url":"/filing/0000915840-25-000028#line-1","is_derivative":false,"issuer_cik":"0000915840","issuer_name":"BEAZER HOMES USA INC","issuer_ticker":"BZH","issuer_name_source":null,"issuer_url":"/issuer/0000915840","owner_cik":"0001343811","owner_name":"Provencio Norma Ann","owner_display_name":"Provencio Norma Ann","owner_url":"/insider/0001343811","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":21.93,"price_display":"21.93","price_state":"stated","total_value":109650.0,"total_display":"109,650.00","total_whole":"109,650","shares_owned_after":10600.0,"shares_owned_after_display":"10,600","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-10","filed_date":"2025-02-10","scope":"insider"},{"id":6514606,"accession":"0001179110-14-012288","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-012288","line_url":"/filing/0001179110-14-012288#line-1","is_derivative":false,"issuer_cik":"0000915840","issuer_name":"BEAZER HOMES USA INC","issuer_ticker":"BZH","issuer_name_source":null,"issuer_url":"/issuer/0000915840","owner_cik":"0001343811","owner_name":"Provencio Norma Ann","owner_display_name":"Provencio Norma Ann","owner_url":"/insider/0001343811","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":16.256,"price_display":"16.26","price_state":"stated","total_value":48768.0,"total_display":"48,768.00","total_whole":"48,768","shares_owned_after":5600.0,"shares_owned_after_display":"5,600","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-01","filed_date":"2014-08-04","scope":"insider"},{"id":6512104,"accession":"0000885590-14-000033","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000885590-14-000033","line_url":"/filing/0000885590-14-000033#line-2","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001343811","owner_name":"Provencio Norma Ann","owner_display_name":"Provencio Norma Ann","owner_url":"/insider/0001343811","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":132.1771,"price_display":"132.18","price_state":"stated","total_value":660885.5,"total_display":"660,885.50","total_whole":"660,886","shares_owned_after":137495.0,"shares_owned_after_display":"137,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-01","filed_date":"2014-04-02","scope":"insider"},{"id":6813951,"accession":"0000885590-14-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-14-000026","line_url":"/filing/0000885590-14-000026#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001343811","owner_name":"Provencio Norma Ann","owner_display_name":"Provencio Norma Ann","owner_url":"/insider/0001343811","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":141.6151,"price_display":"141.62","price_state":"stated","total_value":708075.5,"total_display":"708,075.50","total_whole":"708,076","shares_owned_after":142206.0,"shares_owned_after_display":"142,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-03","filed_date":"2014-03-05","scope":"insider"},{"id":6951932,"accession":"0000885590-14-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-14-000017","line_url":"/filing/0000885590-14-000017#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001343811","owner_name":"Provencio Norma Ann","owner_display_name":"Provencio Norma Ann","owner_url":"/insider/0001343811","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":136.2316,"price_display":"136.23","price_state":"stated","total_value":681158.0,"total_display":"681,158.00","total_whole":"681,158","shares_owned_after":147206.0,"shares_owned_after_display":"147,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-03","filed_date":"2014-02-04","scope":"insider"},{"id":6329856,"accession":"0000885590-14-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-14-000009","line_url":"/filing/0000885590-14-000009#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001343811","owner_name":"Provencio Norma Ann","owner_display_name":"Provencio Norma Ann","owner_url":"/insider/0001343811","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":132.9994,"price_display":"133.00","price_state":"stated","total_value":664997.0,"total_display":"664,997.00","total_whole":"664,997","shares_owned_after":152206.0,"shares_owned_after_display":"152,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-13","filed_date":"2014-01-14","scope":"insider"},{"id":5349661,"accession":"0000885590-13-000096","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-13-000096","line_url":"/filing/0000885590-13-000096#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001343811","owner_name":"Provencio Norma Ann","owner_display_name":"Provencio Norma Ann","owner_url":"/insider/0001343811","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":106.6972,"price_display":"106.70","price_state":"stated","total_value":533486.0,"total_display":"533,486.00","total_whole":"533,486","shares_owned_after":158647.0,"shares_owned_after_display":"158,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-01","filed_date":"2013-11-05","scope":"insider"},{"id":5275147,"accession":"0000885590-13-000081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-13-000081","line_url":"/filing/0000885590-13-000081#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001343811","owner_name":"Provencio Norma Ann","owner_display_name":"Provencio Norma Ann","owner_url":"/insider/0001343811","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":100.25,"price_display":"100.25","price_state":"stated","total_value":401000.0,"total_display":"401,000.00","total_whole":"401,000","shares_owned_after":163282.0,"shares_owned_after_display":"163,282","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-06","filed_date":"2013-09-11","scope":"insider"},{"id":4430258,"accession":"0000885590-13-000080","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-13-000080","line_url":"/filing/0000885590-13-000080#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001343811","owner_name":"Provencio Norma Ann","owner_display_name":"Provencio Norma Ann","owner_url":"/insider/0001343811","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":99.68,"price_display":"99.68","price_state":"stated","total_value":498400.0,"total_display":"498,400.00","total_whole":"498,400","shares_owned_after":167282.0,"shares_owned_after_display":"167,282","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-03","filed_date":"2013-09-04","scope":"insider"},{"id":4515231,"accession":"0000885590-13-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-13-000050","line_url":"/filing/0000885590-13-000050#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001343811","owner_name":"Provencio Norma Ann","owner_display_name":"Provencio Norma Ann","owner_url":"/insider/0001343811","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":85.2595,"price_display":"85.26","price_state":"stated","total_value":511557.0,"total_display":"511,557.00","total_whole":"511,557","shares_owned_after":171860.0,"shares_owned_after_display":"171,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-11","filed_date":"2013-06-13","scope":"insider"},{"id":2298030,"accession":"0001179110-12-016185","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-12-016185","line_url":"/filing/0001179110-12-016185#line-1","is_derivative":false,"issuer_cik":"0000915840","issuer_name":"BEAZER HOMES USA INC","issuer_ticker":"BZH","issuer_name_source":null,"issuer_url":"/issuer/0000915840","owner_cik":"0001343811","owner_name":"Provencio Norma Ann","owner_display_name":"Provencio Norma Ann","owner_url":"/insider/0001343811","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3280.0,"shares_display":"3,280","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":9360.0,"shares_owned_after_display":"9,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-14","filed_date":"2012-11-16","scope":"insider"},{"id":3149674,"accession":"0000885590-12-000033","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000885590-12-000033","line_url":"/filing/0000885590-12-000033","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001343811","owner_name":"Provencio Norma Ann","owner_display_name":"Provencio Norma Ann","owner_url":"/insider/0001343811","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4225.0,"shares_display":"4,225","price_per_share":47.742899408284025,"price_display":"47.74","price_state":"stated","total_value":201713.75,"total_display":"201,713.75","total_whole":"201,714","shares_owned_after":167430.0,"shares_owned_after_display":"167,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-22","filed_date":"2012-05-24","scope":"insider","n_lines":3},{"id":8952787,"accession":"0001179110-11-015561","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-11-015561","line_url":"/filing/0001179110-11-015561#line-1","is_derivative":false,"issuer_cik":"0000915840","issuer_name":"BEAZER HOMES USA INC","issuer_ticker":"BZH","issuer_name_source":null,"issuer_url":"/issuer/0000915840","owner_cik":"0001343811","owner_name":"Provencio Norma Ann","owner_display_name":"Provencio Norma Ann","owner_url":"/insider/0001343811","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13000.0,"shares_display":"13,000","price_per_share":1.97,"price_display":"1.97","price_state":"stated","total_value":25610.0,"total_display":"25,610.00","total_whole":"25,610","shares_owned_after":13000.0,"shares_owned_after_display":"13,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-11-22","filed_date":"2011-11-22","scope":"insider"},{"id":9049476,"accession":"0000885590-11-000055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000885590-11-000055","line_url":"/filing/0000885590-11-000055","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001343811","owner_name":"Provencio Norma Ann","owner_display_name":"Provencio Norma Ann","owner_url":"/insider/0001343811","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2255.0,"shares_display":"2,255","price_per_share":40.86662971175166,"price_display":"40.87","price_state":"stated","total_value":92154.25,"total_display":"92,154.25","total_whole":"92,154","shares_owned_after":161513.0,"shares_owned_after_display":"161,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-09","filed_date":"2011-08-11","scope":"insider","n_lines":2},{"id":9186702,"accession":"0000885590-11-000026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000885590-11-000026","line_url":"/filing/0000885590-11-000026#line-2","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001343811","owner_name":"Provencio Norma Ann","owner_display_name":"Provencio Norma Ann","owner_url":"/insider/0001343811","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":49.85,"price_display":"49.85","price_state":"stated","total_value":49850.0,"total_display":"49,850.00","total_whole":"49,850","shares_owned_after":155007.0,"shares_owned_after_display":"155,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-16","filed_date":"2011-05-17","scope":"insider"},{"id":9186701,"accession":"0000885590-11-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-11-000026","line_url":"/filing/0000885590-11-000026#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001343811","owner_name":"Provencio Norma Ann","owner_display_name":"Provencio Norma Ann","owner_url":"/insider/0001343811","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":51.24,"price_display":"51.24","price_state":"stated","total_value":51240.0,"total_display":"51,240.00","total_whole":"51,240","shares_owned_after":154007.0,"shares_owned_after_display":"154,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-13","filed_date":"2011-05-17","scope":"insider"},{"id":9201751,"accession":"0000885590-11-000019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-11-000019","line_url":"/filing/0000885590-11-000019","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001343811","owner_name":"Provencio Norma Ann","owner_display_name":"Provencio Norma Ann","owner_url":"/insider/0001343811","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1575.0,"shares_display":"1,575","price_per_share":39.873650793650796,"price_display":"39.87","price_state":"stated","total_value":62801.0,"total_display":"62,801.00","total_whole":"62,801","shares_owned_after":152432.0,"shares_owned_after_display":"152,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-04","filed_date":"2011-04-11","scope":"insider","n_lines":3},{"id":9079196,"accession":"0000885590-11-000010","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000885590-11-000010","line_url":"/filing/0000885590-11-000010","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001343811","owner_name":"Provencio Norma Ann","owner_display_name":"Provencio Norma Ann","owner_url":"/insider/0001343811","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1575.0,"shares_display":"1,575","price_per_share":39.873650793650796,"price_display":"39.87","price_state":"stated","total_value":62801.0,"total_display":"62,801.00","total_whole":"62,801","shares_owned_after":117404.0,"shares_owned_after_display":"117,404","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-04","filed_date":"2011-03-08","scope":"insider","n_lines":3},{"id":9201748,"accession":"0000885590-11-000018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000885590-11-000018","line_url":"/filing/0000885590-11-000018","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001343811","owner_name":"Provencio Norma Ann","owner_display_name":"Provencio Norma Ann","owner_url":"/insider/0001343811","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":24.75,"price_display":"24.75","price_state":"stated","total_value":123750.0,"total_display":"123,750.00","total_whole":"123,750","shares_owned_after":148009.0,"shares_owned_after_display":"148,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-10","filed_date":"2011-04-11","scope":"insider","n_lines":2},{"id":5591461,"accession":"0001209499-09-000101","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209499-09-000101","line_url":"/filing/0001209499-09-000101#line-1","is_derivative":false,"issuer_cik":"0000930184","issuer_name":"VALEANT PHARMACEUTICALS INTERNATIONAL","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000930184","owner_cik":"0001343811","owner_name":"Provencio Norma Ann","owner_display_name":"Provencio Norma Ann","owner_url":"/insider/0001343811","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":33.25,"price_display":"33.25","price_state":"stated","total_value":33250.0,"total_display":"33,250.00","total_whole":"33,250","shares_owned_after":38908.0,"shares_owned_after_display":"38,908","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-12","filed_date":"2009-11-12","scope":"insider"},{"id":5969064,"accession":"0001209500-09-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209500-09-000028","line_url":"/filing/0001209500-09-000028#line-1","is_derivative":false,"issuer_cik":"0000930184","issuer_name":"VALEANT PHARMACEUTICALS INTERNATIONAL","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000930184","owner_cik":"0001343811","owner_name":"Provencio Norma Ann","owner_display_name":"Provencio Norma Ann","owner_url":"/insider/0001343811","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":17.7455,"price_display":"17.75","price_state":"stated","total_value":44363.75,"total_display":"44,363.75","total_whole":"44,364","shares_owned_after":28210.0,"shares_owned_after_display":"28,210","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-26","filed_date":"2009-03-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":29,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":21,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":29},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000915840","name":"BEAZER HOMES USA INC","url":"/issuer/0000915840","role":"Director","n_filings":4,"first_seen":"2011-11-22","last_seen":"2025-02-10"},{"type":"issuer","type_label":"ISSUER","cik":"0000885590","name":"Valeant Pharmaceuticals International, Inc.","url":"/issuer/0000885590","role":"Director","n_filings":14,"first_seen":"2011-03-08","last_seen":"2014-04-02"},{"type":"issuer","type_label":"ISSUER","cik":"0000930184","name":"VALEANT PHARMACEUTICALS INTERNATIONAL","url":"/issuer/0000930184","role":"Director","n_filings":2,"first_seen":"2009-03-02","last_seen":"2009-11-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001343811","retrieved_at":"2026-08-24T18:12:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}